Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

David J. Lewis

Novartis Pharma GmbH, Germany

Poster(s):

(BSPOT21) Changes in adverse event reporting of neurodevelopmental disorders after maternal valproate exposure, following a major scientific publication and regulatory decisions, a contribution of the ConcePTION project

Tuesday, August 27, 2024
8:00 AM – 6:00 PM CEST